Cargando…
Clozapine-Induced Gastrointestinal Hypomotility: A 22-Year Bi-National Pharmacovigilance Study of Serious or Fatal ‘Slow Gut’ Reactions, and Comparison with International Drug Safety Advice
INTRODUCTION: Clozapine is the preferred antipsychotic for treatment-resistant schizophrenia, but has significant adverse effects, including gastrointestinal hypomotility or ‘slow gut’, which may result in severe constipation, ileus, bowel obstruction, and even death. These gastrointestinal effects...
Autores principales: | Every-Palmer, Susanna, Ellis, Pete M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533872/ https://www.ncbi.nlm.nih.gov/pubmed/28623627 http://dx.doi.org/10.1007/s40263-017-0448-6 |
Ejemplares similares
-
Clozapine-treated Patients Have Marked Gastrointestinal Hypomotility, the Probable Basis of Life-threatening Gastrointestinal Complications: A Cross Sectional Study
por: Every-Palmer, Susanna, et al.
Publicado: (2016) -
Clozapine-induced Gastrointestinal Hypomotility — New Objective Evidence for an Underestimated Side-effect()
por: Hasan, Alkomiet
Publicado: (2016) -
Disorders of gastrointestinal hypomotility
por: Bielefeldt, Klaus, et al.
Publicado: (2016) -
Management of Ineffective Esophageal Hypomotility
por: Jandee, Sawangpong, et al.
Publicado: (2021) -
Spatiotemporal Mapping Techniques Show Clozapine Impairs Neurogenic and Myogenic Patterns of Activity in the Colon of the Rabbit in a Dose-Dependent Manner
por: Every-Palmer, Susanna, et al.
Publicado: (2017)